ICUI ICU Medical, Inc. - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$159.38
· % 处于52周区间
· 高于低点
· 至高点
$112.5052周低点
$192.8552周高点
市值 (MRQ)
$3.99B
P/E (TTM)
133.9
EPS (TTM)
$1.19
收入 (TTM)
$2.16B
ICUI 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$159.38
市值 (MRQ)
$3.99B
P/E (TTM)
133.9
EPS (TTM)
$1.19
收入 (TTM)
$2.16B
ROE (TTM)
1.4%
负债/权益 (MRQ)
0.6
52周区间
$113–$193
ICUI 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2002年3月18日 | 3-for-2 | 正向 |
| 1993年4月1日 | 3-for-2 | 正向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$2.23B2016-12-31 → 2025-12-31
EPS$0.032016-12-31 → 2025-12-31
自由现金流$92M2016-12-31 → 2025-12-31
净利率1.4%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ICUI | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 133.95年均值 ≈928.4 | ≈928.4 | 28.6 | 估值过高 | |
| P/S (TTM) | 1.85年均值 ≈2.0 | ≈2.0 | 2.6 | 低估 | |
| 市净率 (MRQ) | 1.95年均值 ≈2.0 | ≈2.0 | 2.5 | 低估 | |
| 股价/自由现金流 (TTM) | 26.15年均值 ≈30.9 | ≈30.9 | · | · | |
| 市现率 (TTM) | 16.95年均值 ≈17.9 | ≈17.9 | 17.6 | 估值过高 | |
| 市净率（有形资产） (MRQ) | 2.5 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ICUI | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 39.1%5年均值 ≈34.4% | ≈34.4% | 55.0% | 弱 | |
| 营业利润率 (TTM) | 3.3%5年均值 ≈2.4% | ≈2.4% | 11.6% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | 12.7%5年均值 ≈11.5% | ≈11.5% | 14.3% | 弱 | |
| 税前利润率 (TTM) | 0.03% | · | 10.9% | 弱 | |
| 净利润率 (TTM) | 1.4%5年均值 ≈-0.33% | ≈-0.33% | 8.9% | 弱 | |
| ROA (TTM) | 0.74%5年均值 ≈-0.01% | ≈-0.01% | 1.6% | 低于平均水平 | |
| ROE (TTM) | 1.4%5年均值 ≈-0.87% | ≈-0.87% | 4.2% | 低于平均水平 | |
| ROIC | 0.55% | · | 3.2% | 低于平均水平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ICUI | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.65年均值 ≈0.7 | ≈0.7 | 0.5 | 持平 | |
| 流动比率 (MRQ) | 2.45年均值 ≈3.0 | ≈3.0 | 3.0 | 低流动性 | |
| Quick Ratio (速动比率) | 0.45年均值 ≈1.3 | ≈1.3 | 1.6 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | 0.65年均值 ≈0.7 | ≈0.7 | 0.6 | 持平 | |
| Interest Coverage (利息保障倍数) | 0.55年均值 ≈28.8 | ≈28.8 | 4.2 | 低于平均水平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ICUI | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -6.3%5年均值 ≈15.0% | ≈15.0% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -0.72%5年均值 ≈14.1% | ≈14.1% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 11.9% | · | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | -62.5% | · | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | -61.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ICUI | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.6 | ≈0.6 | 0.6 | 弱 | |
| Inventory Turnover (库存周转率) | 2.35年均值 ≈2.6 | ≈2.6 | 2.8 | 弱 | |
| Receivables Turnover (应收账款周转率) | 12.35年均值 ≈12.7 | ≈12.7 | 6.4 | 顶尖 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$171.6K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
25.0%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 10, 2026 | $2.37 | $1.95 | 21.4% |
| 2026年3月31日 | $1.97 | $1.79 | 10.3% | |
| 2025年12月31日 | $1.91 | $1.73 | 10.7% | |
| 2025年9月30日 | $2.03 | $1.46 | 38.9% | |
| 2025年6月30日 | $2.10 | $1.53 | 37.3% | |
| 2025年3月31日 | $1.72 | $1.31 | 31.7% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379M | $342M | $309M | |
| Cost of Revenue | $1.41B | $1.56B | $1.52B | $1.58B | $825M | $810M | $794M | $830M | $867M | $178M | $161M | $158M | |
| Gross Profit | $822M | $825M | $740M | $698M | $491M | $461M | $472M | $570M | $426M | $201M | $181M | $151M | |
| R&D Expense | $87M | $89M | $85M | $93M | $47M | $43M | $49M | $53M | $51M | $13M | $16M | $18M | |
| SG&A Expense | $625M | $639M | $607M | $608M | $303M | $284M | $277M | $320M | $302M | $89M | $83M | $89M | |
| Operating Expenses | $779M | $782M | $717M | $741M | $368M | $363M | $365M | $540M | $439M | $118M | $112M | $112M | |
| Operating Income | $43M | $43M | $23M | $-43M | $123M | $98M | $107M | $30M | $-13M | $83M | $69M | $39M | |
| Interest Expense | $93M | $107M | $103M | $71M | $858.0K | $2M | $549.0K | $709.0K | $2M | $118.0K | $39.0K | · | |
| Other Non-op | $-232.0K | $-13M | $-6M | $-5M | $-2M | $-3M | $8M | $-7M | $-4M | $885.0K | $1M | $755.0K | |
| Pretax Income | $4M | $-66M | $-78M | · | · | $97M | $115M | $22M | $51M | $85M | $70M | $40M | |
| Income Tax | $2M | $52M | $-49M | $-40M | $20M | $11M | $14M | $-6M | $-17M | $22M | $25M | $13M | |
| Net Income | $732.0K | $-118M | $-30M | $-74M | $103M | $87M | $101M | $29M | $69M | $63M | $45M | $26M | |
| EPS (Basic) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.86 | $4.16 | $4.90 | $1.41 | $3.50 | $3.90 | $2.84 | $1.72 | |
| EPS (Diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 | |
| Shares (Basic) | 24,640,000 | 24,388,000 | 24,091,000 | 23,868,000 | 21,206,000 | 20,907,000 | 20,629,000 | 20,394,000 | 19,614,000 | 16,168,000 | 15,848,000 | 15,282,000 | |
| Shares (Diluted) | 24,904,000 | 24,388,000 | 24,091,000 | 23,868,000 | 21,781,000 | 21,591,000 | 21,545,000 | 21,601,000 | 20,858,000 | 17,254,000 | 16,496,000 | 15,647,000 | |
| EBITDA | $244M | $262M | $252M | $192M | $213M | $184M | $184M | $96M | $51M | $102M | $87M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $309M | $255M | $213M | $553M | $396M | $269M | $345M | $290M | $445M | $336M | $276M | |
| Short-term Investments | · | · | · | · | · | $15M | $24M | $37M | $10M | $0 | $41M | $71M | |
| Receivables | $181M | $183M | $162M | $222M | $106M | $124M | $202M | $176M | $113M | $56M | $58M | $39M | |
| Inventory | $616M | $585M | $709M | $696M | $290M | $315M | $338M | $311M | $289M | $49M | $44M | $37M | |
| Prepaid Expense | $86M | $82M | $74M | $89M | $47M | $41M | $34M | $46M | $41M | $7M | $8M | $6M | |
| Other Current Assets | $26M | $23M | $4M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Current Assets | $1.19B | $1.44B | $1.22B | $1.24B | $1.03B | $921M | $882M | $927M | $865M | $569M | $505M | $433M | |
| PP&E (Net) | $452M | $443M | $613M | $636M | $468M | $467M | $456M | $433M | $399M | $86M | $74M | $86M | |
| PP&E (Gross) | $1.10B | $1.04B | $1.24B | $1.16B | $905M | $843M | $776M | $695M | $609M | $244M | $223M | $225M | |
| Accum. Depreciation | $646M | $593M | $624M | $526M | $437M | $376M | $320M | $262M | $210M | $158M | $149M | $139M | |
| Goodwill | $1.50B | $1.43B | $1.47B | $1.45B | $43M | $33M | $31M | $11M | $12M | $6M | $6M | $1M | |
| Intangibles | $634M | $741M | $871M | $983M | $188M | $197M | $211M | $133M | $144M | $22M | $24M | $7M | |
| Other Non-current Assets | $63M | $65M | $94M | $105M | $64M | $55M | $49M | $40M | $38M | $0 | · | · | |
| Total Assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $705M | $627M | $541M | |
| Accounts Payable | $154M | $148M | $150M | $216M | $81M | $72M | $129M | $120M | $78M | $15M | $14M | $11M | |
| Accrued Liabilities | $315M | $307M | $268M | $243M | $118M | $97M | $118M | $129M | $132M | $26M | $29M | $17M | |
| Current Liabilities | $499M | $556M | $482M | $495M | $201M | $195M | $248M | $249M | $210M | $41M | $43M | $29M | |
| Capital Leases | $44M | $41M | $53M | $61M | $34M | $41M | $29M | $0 | $0 | · | · | · | |
| Deferred Tax | $38M | $49M | $56M | $126M | $1M | $2M | $2M | $721.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | $90M | $67M | $100M | $114M | $42M | $48M | $33M | · | · | · | · | · | |
| Long-term Debt | $1.28B | $1.58B | $1.63B | $1.65B | $0 | · | · | · | · | · | · | · | |
| Total Debt | $1.28B | $1.58B | $1.63B | $1.65B | · | · | · | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $691M | $690M | $808M | $838M | $912M | $809M | $722M | $621M | $586M | $517M | $454M | $409M | |
| Treasury Stock | $22.0K | $92.0K | $262.0K | $243.0K | $27.0K | $39.0K | $157.0K | $95.0K | $0 | $14.0K | $0 | $0 | |
| AOCI | $-35M | $-139M | $-53M | $-81M | $-19M | $-2M | $-15M | $-17M | $-15M | $-21M | $-21M | $-10M | |
| Stockholders' Equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B | $1.50B | $1.38B | $1.26B | $1.20B | $660M | $580M | $508M | |
| Liabilities + Equity | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $705M | $627M | $541M | |
| Shares Outstanding | 24,688,000 | 24,517,000 | 24,141,000 | 23,993,000 | 21,280,000 | 21,058,000 | 20,742,000 | 20,491,229 | 20,210,054 | 16,337,670 | 16,086,000 | 15,595,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $201M | $220M | $229M | $235M | $90M | $86M | $77M | $75M | $67M | $19M | $18M | $19M | |
| Stock-based Comp | $56M | $47M | $41M | $36M | $27M | $24M | $22M | $24M | $19M | $15M | $13M | $10M | |
| Deferred Tax | $-14M | $6M | $-70M | $-61M | $-11M | $-5M | $-4M | $-18M | $-26M | $-3M | $4M | $-1M | |
| Amort. of Intangibles | $131M | $134M | $132M | $139M | $24M | $23M | $18M | $17M | $15M | $3M | $2M | $2M | |
| Restructuring | · | · | $6M | $10M | $-2M | $8M | $8M | $4M | $19M | $800.0K | $7M | $4M | |
| Other Non-cash | $-64M | $50M | $-2M | $-198M | $59M | $31M | $-94M | $50M | $25M | $-5M | $-25M | · | |
| Operating Cash Flow | $180M | $204M | $166M | $-62M | $268M | $223M | $102M | $160M | $154M | $90M | $64M | $66M | |
| CapEx | $88M | $79M | $84M | $90M | $69M | $92M | $97M | $93M | $74M | $23M | $13M | $17M | |
| Investing Cash Flow | $122M | $-89M | $-88M | $-1.91B | $-91M | $-98M | $-167M | $-103M | $-267M | $16M | $-11M | $-22M | |
| Net Debt Issued | $-303M | $-51M | $-30M | $-22M | $0 | $-150M | $0 | $0 | $-75M | · | · | · | |
| Stock Repurchased | $9M | $12M | $9M | $11M | $8M | $13M | $19M | $6M | $4M | $17M | $2M | $6M | |
| Net Stock Activity | $-9M | $-12M | $-9M | $-11M | $-8M | $-13M | $-19M | $-6M | $-4M | $-17M | $-2M | · | |
| Financing Cash Flow | $-312M | $-56M | $-36M | $1.64B | $-17M | $-40.0K | $-11M | $8M | $-44M | $2M | $16M | $14M | |
| Net Change in Cash | $-603.0K | $54M | $45M | $-344M | $157M | $127M | $-76M | $55M | $-155M | $109M | $60M | $50M | |
| Free Cash Flow | $92M | $125M | $82M | $-152M | $199M | $131M | $5M | $67M | $80M | $67M | $42M | · | |
| Levered FCF | $51M | · | · | · | · | $129M | $4M | $67M | $77M | · | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% | 36.3% | 37.3% | 40.7% | 33.0% | 53.1% | 52.9% | · | |
| Operating Margin | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% | 7.7% | 8.5% | 1.5% | -1.2% | 21.9% | 20.1% | · | |
| Net Margin | 0.03% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% | 13.2% | · | |
| Pretax Margin | 0.20% | · | · | · | · | 7.7% | 9.1% | 1.6% | 4.0% | 22.4% | 20.4% | · | |
| EBITDA Margin | 10.9% | 11.0% | 11.1% | 8.4% | 16.2% | 14.5% | 14.5% | 6.9% | 4.0% | 26.9% | 25.4% | · | |
| ROA | 0.02% | -2.7% | -0.67% | -2.3% | 5.7% | 5.0% | 6.2% | 1.9% | 6.2% | 9.5% | 7.7% | · | |
| ROE | 0.03% | -5.9% | -1.4% | -3.5% | 6.4% | 5.9% | 7.4% | 2.3% | 7.4% | 10.2% | 8.3% | · | |
| ROIC | 0.55% | · | · | · | · | 5.8% | 6.9% | 2.2% | -1.7% | 9.3% | 7.6% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.6 | 2.5 | 2.5 | 5.1 | 4.7 | 3.6 | 3.7 | 4.1 | 14.0 | 11.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.9 | 0.9 | 3.3 | 2.7 | 2.0 | 2.2 | 2.0 | 12.4 | 10.2 | · | |
| Debt / Equity | 0.6 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.8 | 0.7 | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | 0.5 | 0.4 | 0.2 | -0.6 | 143.6 | 56.0 | 195.6 | 30.5 | -7.4 | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.5 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.3 | 2.4 | 2.2 | 3.2 | 2.7 | 2.5 | 2.4 | 2.8 | 3.0 | 3.8 | 4.0 | · | |
| Receivables Turnover | 12.3 | 13.8 | 11.8 | 13.9 | 11.4 | 7.8 | 6.7 | 9.7 | 15.3 | 6.7 | 7.1 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $86.03 | $80.16 | $87.96 | · | $75.94 | $71.34 | $66.40 | $61.67 | $59.29 | $40.41 | $36.05 | · | |
| Revenue / Share | $89.59 | $97.67 | $93.77 | $95.53 | $60.43 | $58.87 | $58.77 | $64.81 | $61.97 | $21.99 | $20.71 | · | |
| Cash Flow / Share | $7.22 | $8.37 | $6.90 | $-2.60 | $12.28 | $10.32 | $4.73 | $7.42 | $7.40 | $5.21 | $3.33 | · | |
| Cash / Share | · | $12.59 | $10.55 | · | $25.98 | $18.81 | $12.95 | $16.83 | $14.35 | $27.24 | $20.90 | · | |
| EPS (TTM) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -6.3% | 5.4% | -0.92% | 73.2% | 3.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.72% | 21.9% | 21.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 17.9% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -62.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 18.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -61.5% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379M | $342M | $309M | |
| Net Income TTM | $732.0K | $-118M | $-30M | $-74M | $103M | $87M | $101M | $29M | $69M | $63M | $45M | $26M | |
| Market Cap | $3.52B | $3.80B | $2.41B | · | $5.05B | $4.52B | $3.88B | $4.71B | $4.37B | $2.41B | $1.81B | · | |
| Enterprise Value | · | $5.08B | $3.78B | · | · | · | · | · | · | · | · | · | |
| P/E | 4755.7 | -32.1 | -81.1 | -50.6 | 50.1 | 53.4 | 39.9 | 172.7 | 65.7 | 40.3 | 41.3 | 48.8 | |
| P/S | 1.6 | 1.6 | 1.1 | · | 3.8 | 3.6 | 3.1 | 3.4 | 3.4 | 6.3 | 5.3 | · | |
| P/B | 1.7 | 1.9 | 1.1 | · | 3.1 | 3.0 | 2.8 | 3.7 | 3.6 | 3.6 | 3.1 | · | |
| P / Tangible Book | · | · | · | · | 3.6 | 3.6 | · | · | · | · | · | · | |
| P / Cash Flow | 19.6 | 18.6 | 14.5 | · | 18.9 | 20.3 | 38.1 | 29.4 | 28.3 | 26.8 | 33.1 | · | |
| P / FCF | 38.4 | 30.5 | 29.3 | · | 25.4 | 34.5 | 842.7 | 69.7 | 54.6 | 36.2 | 43.3 | · | |
| EV / EBITDA | · | 19.3 | 15.0 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | 40.7 | 45.9 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 2.1 | 1.7 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.02% | -3.1% | -1.2% | -2.0% | 2.0% | 1.9% | 2.5% | 0.58% | 1.5% | 2.5% | 2.4% | 2.1% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $552M | $530M | $541M | $537M | $549M | $605M | $630M | $589M | $596M | $567M | $588M | $553M | $549M | $569M | $578M | $598M | |
| Cost of Revenue | $317M | $324M | $338M | $336M | $341M | $395M | $403M | $384M | $389M | $381M | $416M | $369M | $357M | $377M | $403M | $411M | |
| Gross Profit | $235M | $206M | $203M | $201M | $208M | $210M | $227M | $205M | $207M | $185M | $172M | $184M | $192M | $192M | $175M | $186M | |
| R&D Expense | $23M | $21M | $21M | $21M | $22M | $23M | $22M | $21M | $23M | $22M | $22M | $21M | $22M | $20M | $23M | $23M | |
| SG&A Expense | $152M | $155M | $156M | $153M | $159M | $157M | $159M | $163M | $160M | $158M | $155M | $149M | $151M | $153M | $143M | $153M | |
| Operating Expenses | $196M | $193M | $197M | $187M | $197M | $197M | $190M | $197M | $200M | $196M | $184M | $161M | $190M | $183M | $175M | $187M | |
| Operating Income | $39M | $14M | $6M | $14M | $11M | $13M | $38M | $8M | $8M | $-11M | $-12M | $23M | $3M | $9M | $-222.0K | $-467.0K | |
| Interest Expense | $16M | $16M | $31M | $20M | $21M | $22M | $34M | $25M | $24M | $24M | $32M | $24M | $24M | $23M | $25M | $18M | |
| Other Non-op | $-236.0K | $-1M | $-894.0K | $607.0K | $2M | $-2M | $-6M | $-1M | $-3M | $-2M | $-90.0K | $-4M | $-2M | $-269.0K | $-1M | $-3M | |
| Pretax Income | $23M | $-4M | $-16M | $-3M | $34M | $-11M | $8M | $-18M | $-20M | $-37M | $-37M | $-5M | $-23M | $-13M | · | $-21M | |
| Income Tax | $7M | $-35M | $-3M | $-658.0K | $1M | $5M | $32M | $15M | $2M | $3M | $-20M | $-13M | $-13M | $-4M | $-6M | $-8M | |
| Net Income | $19M | $30M | $-16M | $-3M | $35M | $-15M | $-24M | $-33M | $-21M | $-39M | $-17M | $7M | $-10M | $-10M | $-19M | $-10M | |
| EPS (Basic) | $0.76 | $1.22 | $-0.63 | $-0.14 | $1.43 | $-0.63 | $-0.97 | $-1.35 | $-0.88 | $-1.63 | $-0.71 | $0.30 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | |
| EPS (Diluted) | $0.76 | $1.20 | $-0.63 | $-0.14 | $1.43 | $-0.63 | $-0.97 | $-1.35 | $-0.88 | $-1.63 | $-0.71 | $0.30 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | |
| Shares (Basic) | 25,000,000 | 24,764,000 | · | 24,686,000 | 24,645,000 | 24,539,000 | · | 24,438,000 | 24,393,000 | 24,222,000 | · | 24,132,000 | 24,075,000 | 24,014,000 | · | 23,908,000 | |
| Shares (Diluted) | 25,044,000 | 25,182,000 | · | 24,686,000 | 24,708,000 | 24,539,000 | · | 24,438,000 | 24,393,000 | 24,222,000 | · | 24,368,000 | 24,075,000 | 24,014,000 | · | 23,908,000 | |
| EBITDA | $39M | $64M | · | $14M | $11M | $62M | · | $8M | $8M | $45M | · | $23M | $3M | $65M | · | $-467.0K |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $313M | $303M | $251M | · | $199M | $198M | $224M | · | $247M | |
| Receivables | $184M | $201M | $181M | $192M | $179M | $171M | $183M | $174M | $152M | $145M | · | $162M | $162M | $139M | · | $213M | |
| Inventory | $607M | $606M | $616M | $622M | $616M | $590M | $585M | $692M | $683M | $693M | · | $760M | $775M | $748M | · | $625M | |
| Prepaid Expense | $122M | $118M | $86M | $94M | $84M | $75M | $82M | $74M | $81M | $83M | · | $84M | $96M | $87M | · | $94M | |
| Other Current Assets | $34M | $39M | $20M | $23M | $23M | $6M | $23M | $5M | $5M | $4M | · | $3M | $3M | $4M | · | $3M | |
| Current Assets | $1.21B | $1.21B | $1.19B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B | $1.24B | $1.19B | · | $1.22B | $1.24B | $1.21B | · | $1.20B | |
| PP&E (Net) | $447M | $445M | $452M | $456M | $452M | $442M | $443M | $596M | $594M | $603M | · | $609M | $617M | $624M | · | $656M | |
| PP&E (Gross) | $1.12B | $1.11B | $1.10B | $1.09B | $1.08B | $1.05B | $1.04B | $1.28B | $1.26B | $1.25B | · | $1.21B | $1.19B | $1.17B | · | $1.15B | |
| Accum. Depreciation | $676M | $661M | $646M | $636M | $630M | $608M | $593M | $685M | $664M | $644M | · | $597M | $575M | $550M | · | $498M | |
| Goodwill | $1.48B | $1.49B | $1.50B | $1.50B | $1.50B | $1.46B | $1.43B | $1.48B | $1.45B | $1.46B | $1.47B | $1.44B | $1.46B | $1.46B | $1.45B | $1.37B | |
| Intangibles | $568M | $599M | $634M | $665M | $698M | $717M | $741M | $786M | $806M | $837M | · | $891M | $930M | $958M | · | $1.02B | |
| Other Non-current Assets | $63M | $63M | $63M | $61M | $61M | $65M | $65M | $87M | $95M | $97M | · | $108M | $100M | $102M | · | $111M | |
| Total Assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | · | $4.38B | $4.46B | $4.47B | · | $4.45B | |
| Accounts Payable | $149M | $174M | $154M | $172M | $169M | $180M | $148M | $169M | $156M | $152M | · | $149M | $167M | $186M | · | $205M | |
| Accrued Liabilities | $322M | $315M | $315M | $316M | $314M | $279M | $307M | $326M | $300M | $248M | · | $251M | $255M | $235M | · | $244M | |
| Current Liabilities | $498M | $518M | $499M | $493M | $483M | $549M | $556M | $550M | $512M | $455M | · | $464M | $484M | $462M | · | $489M | |
| Capital Leases | $37M | $41M | $44M | $47M | $49M | $48M | $41M | $45M | $52M | $50M | · | $57M | $60M | $63M | · | $63M | |
| Deferred Tax | $12M | $15M | $38M | $41M | $43M | $45M | $49M | $49M | $54M | $56M | · | $78M | $90M | $115M | · | $154M | |
| Other Non-current Liabilities | $71M | $82M | · | $94M | $96M | $78M | · | $80M | $91M | $103M | · | $100M | $110M | $114M | · | $119M | |
| Long-term Debt | $1.23B | $1.28B | $1.28B | $1.31B | $1.34B | $1.54B | $1.58B | $1.59B | $1.61B | $1.62B | · | $1.63B | $1.64B | $1.65B | · | $1.65B | |
| Total Debt | $1.23B | $1.28B | · | $1.31B | $1.34B | $1.54B | · | $1.59B | $1.61B | $1.62B | · | $1.63B | $1.64B | $1.65B | · | $1.65B | |
| Common Stock | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $740M | $721M | $691M | $707M | $710M | $675M | $690M | $714M | $747M | $768M | · | $825M | $818M | $828M | · | $853M | |
| Treasury Stock | $23M | $25M | $22.0K | $12.0K | $6.0K | $60.0K | $92.0K | $208.0K | $518.0K | $5M | · | $672.0K | $2M | $8M | · | $126.0K | |
| AOCI | $-43M | $-52M | $-35M | $-33M | $-33M | $-105M | $-139M | $-62M | $-92M | $-70M | $-53M | $-85M | $-49M | $-62M | $-81M | $-166M | |
| Stockholders' Equity | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B | $2.04B | · | $2.12B | $2.10B | $2.11B | $2.10B | $2.09B | $2.01B | |
| Liabilities + Equity | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | · | $4.38B | $4.46B | $4.47B | · | $4.45B | |
| Shares Outstanding | 25,007,000 | 24,993,000 | 24,688,000 | 24,686,000 | 24,685,000 | 24,611,000 | 24,517,000 | 24,459,000 | 24,425,000 | 24,365,000 | · | 24,139,000 | 24,104,000 | 24,064,000 | · | 23,979,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $50M | $50M | $51M | $51M | $50M | $49M | $53M | $56M | $55M | $56M | $57M | $58M | $58M | $56M | $57M | $59M | |
| Stock-based Comp | $12M | $14M | $14M | $15M | $14M | $12M | $13M | $12M | $11M | $12M | $11M | $11M | $10M | $9M | $7M | $9M | |
| Amort. of Intangibles | $33M | $33M | $33M | $33M | $33M | $33M | $34M | $34M | $33M | $33M | $33M | $33M | $33M | $32M | $30M | $36M | |
| Restructuring | $7M | $7M | · | $6M | $8M | $7M | · | $4M | $8M | $5M | · | $1M | $1M | $3M | · | $2M | |
| Other Non-cash | · | $-55M | · | · | · | $5M | · | · | · | · | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $80M | $39M | $61M | $57M | $11M | $51M | $40M | $36M | $82M | $46M | $91M | $35M | $-1M | $41M | $-2M | $2M | |
| CapEx | $19M | $11M | $25M | $29M | $20M | $15M | $24M | $20M | $19M | $16M | $30M | $21M | $18M | $14M | $22M | $21M | |
| Investing Cash Flow | $-20M | $-11M | $-18M | $-30M | $187M | $-17M | $-27M | $-23M | $-22M | $-18M | $-31M | $-25M | $-18M | $-15M | $-24M | $-13M | |
| Net Debt Issued | · | $-5M | · | · | · | $-48M | · | · | · | $-13M | · | · | · | $-7M | · | · | |
| Financing Cash Flow | $-50M | $-44M | $-34M | $-26M | $-195M | $-56M | $-8M | $-10M | $-10M | $-27M | $-8M | $-6M | $-6M | $-16M | $-10M | $3M | |
| Net Change in Cash | $10M | $-20M | $8M | $-293.0K | $10M | $-19M | $-4M | $10M | $51M | $-3M | $57M | $1M | $-25M | $12M | $-35M | $-12M | |
| Free Cash Flow | · | $28M | · | · | · | $37M | · | · | · | $30M | · | · | · | $27M | · | · | |
| Levered FCF | · | $155M | · | · | · | $5M | · | · | · | $4M | · | · | · | $11M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.6% | 38.9% | · | 37.4% | 37.9% | 34.8% | · | 34.8% | 34.8% | 32.7% | · | 33.2% | 35.0% | 33.8% | · | 31.2% | |
| Operating Margin | 7.1% | 2.6% | · | 2.5% | 1.9% | 2.1% | · | 1.4% | 1.3% | -1.9% | · | 4.1% | 0.50% | 1.7% | · | -0.08% | |
| Net Margin | 3.5% | 5.7% | · | -0.63% | 6.4% | -2.6% | · | -5.6% | -3.6% | · | · | 1.3% | -1.8% | -1.7% | · | -2.2% | |
| Pretax Margin | 4.2% | -0.75% | · | -0.47% | 6.1% | -1.8% | · | -3.0% | -3.3% | -6.5% | · | -0.97% | -4.2% | -2.4% | · | -3.6% | |
| EBITDA Margin | 7.1% | 12.0% | · | 2.5% | 1.9% | 10.3% | · | 1.4% | 1.3% | 7.9% | · | 4.1% | 0.50% | 11.5% | · | -0.08% | |
| ROA | 0.47% | 0.74% | · | -0.08% | 0.84% | -0.37% | · | -0.76% | -0.49% | · | · | 0.16% | -0.22% | -0.21% | · | -0.42% | |
| ROE | 0.89% | 1.5% | · | -0.16% | 1.7% | -0.76% | · | -1.6% | -1.0% | · | · | 0.35% | -0.47% | -0.46% | · | -0.73% | |
| ROIC | 0.80% | -3.1% | · | 0.29% | 0.30% | 0.52% | · | 0.42% | 0.23% | -0.71% | · | -0.83% | 0.03% | 0.18% | · | -0.01% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.3 | · | 2.4 | 2.4 | 2.6 | · | 2.3 | 2.4 | 2.6 | · | 2.6 | 2.6 | 2.6 | · | 2.5 | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.9 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.8 | · | 0.8 | 0.8 | · | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | · | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 2.5 | 0.8 | · | 0.7 | 0.5 | 0.6 | · | 0.3 | 0.3 | -0.4 | · | 0.9 | 0.1 | 0.4 | · | -0.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.9 | |
| Receivables Turnover | 3.0 | 2.9 | · | 2.9 | 3.3 | 3.8 | · | 3.5 | 3.8 | 4.0 | · | 3.0 | 2.9 | 3.3 | · | 3.6 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $86.05 | $84.50 | · | $86.17 | $85.71 | $80.76 | · | $83.76 | $83.43 | · | · | $86.93 | $87.74 | $87.28 | · | $83.94 | |
| Revenue / Share | $22.03 | $21.06 | · | $21.75 | $22.21 | $24.64 | · | $24.11 | $24.45 | $23.39 | · | $22.71 | $22.82 | $23.68 | · | $25.01 | |
| Cash Flow / Share | · | $1.55 | · | · | · | $2.09 | · | · | · | $1.89 | · | · | · | $1.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | $12.78 | $12.39 | $10.32 | · | $8.24 | $8.20 | $9.32 | · | $10.29 | |
| EPS (TTM) | $1.19 | $1.86 | · | $-0.31 | $-1.52 | $-3.83 | · | $-4.57 | $-2.92 | $-2.45 | · | $-1.16 | $-2.01 | $-1.91 | · | $-1.56 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.16B | $2.16B | · | $2.32B | $2.37B | $2.42B | · | $2.34B | $2.30B | $2.26B | · | $2.25B | $2.29B | $2.31B | · | $2.04B | |
| Net Income TTM | $30M | $46M | · | $-7M | $-37M | $-94M | · | $-111M | $-71M | $-59M | · | $-31M | $-48M | $-46M | · | $-35M | |
| Market Cap | $3.67B | $3.23B | · | $2.96B | $3.26B | $3.42B | · | $4.46B | $2.90B | $2.61B | · | $2.87B | $4.30B | $3.97B | · | $3.61B | |
| Enterprise Value | · | · | · | · | · | · | · | $5.74B | $4.20B | $3.98B | · | $4.31B | $5.74B | $5.39B | · | $5.02B | |
| P/E | 123.2 | 69.4 | · | -387.0 | -86.9 | -36.3 | · | -39.9 | -40.7 | -43.8 | · | -102.6 | -88.7 | -86.4 | · | -96.5 | |
| P/S | 1.7 | 1.5 | · | 1.3 | 1.4 | 1.4 | · | 1.9 | 1.3 | 1.2 | · | 1.3 | 1.9 | 1.7 | · | 1.8 | |
| P/B | 1.7 | 1.5 | · | 1.4 | 1.5 | 1.7 | · | 2.2 | 1.4 | · | · | 1.4 | 2.0 | 1.9 | · | 1.8 | |
| P / Tangible Book | 36.7 | 117.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 83.0 | · | · | · | 66.6 | · | · | · | 57.1 | · | · | · | 96.2 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 2.5 | 1.8 | 1.8 | · | 1.9 | 2.5 | 2.3 | · | 2.5 | |
| Earnings Yield | 0.81% | 1.4% | · | -0.26% | -1.1% | -2.8% | · | -2.5% | -2.5% | -2.3% | · | -0.97% | -1.1% | -1.2% | · | -1.0% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| 毛利率 % | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% |
| 营业利润率 % | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% |
| 净收入 | $732.0K | $-118M | $-30M | $-74M | $103M |
| 稀释后每股收益 (EPS) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.6 | 0.8 | 0.8 | 0.8 | · |
| 流动比率 | 2.4 | 2.6 | 2.5 | 2.5 | 5.1 |
| 速动比率 | 0.4 | 0.9 | 0.9 | 0.9 | 3.3 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $92M | $125M | $82M | $-152M | $199M |
机构持有人 (13F) 305 家申报者 · $4.1B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
305
持有价值
$4.1B
新仓位
43
已退出持仓
30
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 43 (-6 与上一季度对比) | 30 (-15 与上一季度对比) | 118 (+28 与上一季度对比) | 82 (-14 与上一季度对比) | -1.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $550249759 | 3753409 | 13.48% | 股份 |
| VANGUARD GROUP INC | $387312811 | 2714746 | 9.49% | 股份 |
| JANUS HENDERSON GROUP PLC | $345607263 | 2676012 | 8.47% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $215587468 | 1470583 | 5.28% | 股份 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $190305412 | 1298127 | 4.66% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $164666544 | 1123237 | 4.03% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $154443449 | 1053476 | 3.78% | 股份 |
| STATE STREET CORP | $150177172 | 1024369 | 3.68% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $109340684 | 739138 | 2.68% | 股份 |
| AMERIPRISE FINANCIAL INC | $101091847 | 689573 | 2.48% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $96836293 | 660423 | 2.37% | 股份 |
| River Road Asset Management, LLC | $91814114 | 626290 | 2.25% | 股份 |
| CITADEL ADVISORS LLC | $78610585 | 536225 | 1.93% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $66157502 | 451279 | 1.62% | 股份 |
| JPMORGAN CHASE & CO | $65312452 | 440468 | 1.60% | 股份 |
| GOLDMAN SACHS GROUP INC | $61182264 | 417342 | 1.50% | 股份 |
| MORGAN STANLEY | $54620878 | 372583 | 1.34% | 股份 |
| BANK OF AMERICA CORP /DE/ | $54059336 | 368754 | 1.32% | 股份 |
| TORONTO DOMINION BANK | $52486172 | 358023 | 1.29% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $48532223 | 331052 | 1.19% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $48227000 | 328969 | 1.18% | 股份 |
| REINHART PARTNERS, LLC. | $46147615 | 314768 | 1.13% | 股份 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $43614563 | 297505 | 1.07% | 股份 |
| NORTHERN TRUST CORP | $43361202 | 295779 | 1.06% | 股份 |
| FMR LLC | $41516428 | 283195 | 1.02% | 股份 |
| FEDERATED HERMES, INC. | $35688010 | 243438 | 0.87% | 股份 |
| BROWN ADVISORY INC | $34772232 | 237191 | 0.85% | 股份 |
| OBERWEIS ASSET MANAGEMENT INC/ | $34751530 | 237050 | 0.85% | 股份 |
| SEGALL BRYANT & HAMILL, LLC | $32552823 | 222052 | 0.80% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $31094299 | 212103 | 0.76% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $29850399 | 203618 | 0.73% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $28651797 | 195442 | 0.70% | 股份 |
| Bank of New York Mellon Corp | $26966404 | 183945 | 0.66% | 股份 |
| NORGES BANK | $26055658 | 177733 | 0.64% | 股份 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $25241735 | 172181 | 0.62% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $24343810 | 166056 | 0.60% | 股份 |
| Point72 Asset Management, L.P. | $24257755 | 165469 | 0.59% | 股份 |
| Woodline Partners LP | $24087113 | 164305 | 0.59% | 股份 |
| Quantinno Capital Management LP | $23256917 | 158642 | 0.57% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $21841347 | 148986 | 0.54% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $21327368 | 145480 | 0.52% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $18959631 | 129329 | 0.46% | 股份 |
| Defilade Capital Management, L.P. | $15495620 | 105700 | 0.38% | 股份 |
| UBS Group AG | $14515160 | 99012 | 0.36% | 股份 |
| Nuveen, LLC | $14023903 | 95661 | 0.34% | 股份 |
| Invesco Ltd. | $13846957 | 94454 | 0.34% | 股份 |
| GLENMEDE TRUST CO NA | $13638051 | 93029 | 0.33% | 股份 |
| Public Sector Pension Investment Board | $12585170 | 85847 | 0.31% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $10257222 | 79421 | 0.25% | 股份 |
| RHUMBLINE ADVISERS | $9138587 | 62337 | 0.22% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Smiths Group plc, Smiths Group International Holdings Limited ×3 申报 | 2024年7月18日 | · | 初始申报 | · | SEC |
| Pfizer Inc. (“Pfizer”) IRS Identification Nos. of above persons (entities only), C. P. Pharmaceuticals International C.V. (the “Shareholder”) IRS Identification Nos. of above persons (entities only), PFIZER PRODUCTION LLC (“PPL”) IRS Identification Nos. of above persons (entities only), PFIZER MANUFACTURING LLC (“PML” and together with PPL, the “General Partners”) IRS Identification Nos. of above persons (entities only) ×2 申报 | 2018年11月16日 | · | 初始申报 | · | SEC |
| Pfizer Inc. ("Pfizer") IRS Identification Nos. of above persons (entities only), C. P. Pharmaceuticals International C.V. IRS Identification Nos. of above persons (entities only), PFIZER PRODUCTION LLC IRS Identification Nos. of above persons (entities only), PFIZER MANUFACTURING LLC IRS Identification Nos. of above persons (entities only) | 2017年2月13日 | · | 初始申报 | 董事会活动 | SEC |
| 未披露的报告人 | 2002年11月12日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 28 位内幕人士 · 12 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Vivek Jain | Chairman and CEO | 2026年3月15日 M | 126833 | 0 | 0 | $0 |
| Brian Michael Bonnell | Chief Financial Officer | 2026年9月1日 S | 56062 | 0 | 5 | $-2724787 |
| Francis J Obrien | Chief Financial Officer | 2008年2月15日 P | 8046 | 0 | 0 | $0 |
| Christian B. Voigtlander | Chief Operating Officer | 2026年8月11日 S | 37377 | 0 | 1 | $-1633382 |
| Virginia Ruth Sanzone | VP, General Counsel | 2026年9月3日 S | 14604 | 0 | 6 | $-1255170 |
| Daniel Woolson | VP, GM-Infusion Capital | 2026年8月13日 S | 17062 | 0 | 3 | $-1704305 |
| Ben Sousa | Chief Information Officer | 2026年8月12日 S | 3076 | 0 | 1 | $-401220 |
| Kevin J Mcgrody | Chief Accounting Officer | 2022年3月6日 M | 4846 | 0 | 0 | $0 |
| Thomas D Mccall | Vice President and Gen'l Mgr. | 2020年1月17日 M | 7841 | 0 | 0 | $0 |
| Burcar Alison Brummett | Vice President and Gen'l Mgr. | 2019年3月27日 M | 6794 | 0 | 0 | $0 |
| Steven Riggs | VP Operations | 2018年2月11日 M | 3127 | 0 | 0 | $0 |
| Richard A Costello | Vice President Sales | 2014年2月25日 X | 285 | 0 | 0 | $0 |
| Laurie Hernandez | 董事 | 2026年5月13日 A | 4862 | 0 | 0 | $0 |
| David C. Greenberg | 董事 | 2026年5月13日 A | 9214 | 0 | 1 | $-297934 |
| Donald Abbey | 董事 | 2026年5月13日 A | 6004 | 0 | 0 | $0 |
| Kolleen T Kennedy | 董事 | 2026年5月13日 A | 4539 | 0 | 0 | $0 |
| George A Lopez | 董事 | 2024年3月14日 S | 877343 | 0 | 0 | $0 |
| Robert S Swinney | 董事 | 2021年9月15日 S | 20816 | 0 | 0 | $0 |
| Joseph R Saucedo | 董事 | 2018年5月14日 S | 0 | 0 | 0 | $0 |
| Richard Sherman MD | 董事 | 2017年5月16日 M | 69942 | 0 | 0 | $0 |
| Jack Brown | 董事 | 2015年10月5日 X | 19862 | 0 | 0 | $0 |
| John J Connors | 董事 | 2015年6月9日 M | 2456 | 0 | 0 | $0 |
| Michael T Kovalchik | 董事 | 2014年5月9日 M | 4602 | 0 | 0 | $0 |
| Elisha W Finney | · | 2026年8月11日 S | 4871 | 0 | 2 | $-249417 |
| David F Hoffmeister | · | 2026年5月13日 A | 6004 | 0 | 0 | $0 |
| Smiths Group International Holdings Ltd | · | 2024年2月29日 S | 1670000 | 0 | 0 | $0 |
| SMITHS GROUP PLC | · | 2024年2月29日 S | 1670000 | 0 | 0 | $0 |
| Scott E Lamb | · | 2020年2月14日 M | 16274 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 52 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trus... | 2.15% | 23775 SH | 2026年10月2日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.47% | 690 SH | 2026年10月2日 | 每日 |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.27% | 4061 SH | 2026年10月2日 | 每日 |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.24% | 8560 NS | 2026年7月31日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.24% | 116117 NS | 2026年7月31日 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.23% | 21594 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.21% | 35586 SH | 2026年10月2日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.20% | 87418 SH | 2026年8月19日 | 每日 |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.20% | 27578 SH | 2026年8月19日 | 每日 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.19% | 14279 SH | 2026年8月19日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.15% | 6091 NS | 2026年7月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.15% | 11901 NS | 2026年7月31日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.14% | 734 NS | 2026年7月31日 | N-PORT |
| FYT · First Trust Exchange-Traded Alpha... | 0.14% | 1600 NS | 2026年7月31日 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.14% | 17020 SH | 2026年10月2日 | 每日 |
| RSSL · Global X Funds | 0.13% | 11831 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.13% | 632805 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.11% | 142142 SH | 2026年8月19日 | 每日 |
| DFAT · Dimensional ETF Trust | 0.10% | 85853 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.09% | 77820 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.08% | 364019 SH | 2026年8月19日 | 每日 |
| ESML · iShares Trust | 0.07% | 11599 SH | 2026年9月11日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.06% | 11256 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.05% | 71375 SH | 2026年8月19日 | 每日 |
| ISCG · iShares Trust | 0.05% | 2813 SH | 2026年9月11日 | 每日 |
| SMDX · Tidal Trust III | 0.04% | 311 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.04% | 286547 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.04% | 573524 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.03% | 1443 SH | 2026年9月11日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.03% | 1111 NS | 2026年7月31日 | N-PORT |
| FAB · First Trust Exchange-Traded Alpha... | 0.03% | 278 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 58989 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.02% | 2490 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.02% | 3385 NS | 2026年7月31日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.02% | 15263 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 1530 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 792153 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 5438 SH | 2026年8月19日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.01% | 6148 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 7354 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.01% | 32068 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 6145 SH | 2026年9月11日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 19221 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2073 SH | 2026年8月19日 | 每日 |
| IJR · iShares Trust | · | 1525334 SH | 2026年9月10日 | 每日 |
| IJT · iShares Trust | · | 113714 SH | 2026年9月9日 | 每日 |
| IJS · iShares Trust | · | 115864 SH | 2026年9月8日 | 每日 |
| IWN · iShares Trust | · | 232180 SH | 2026年9月11日 | 每日 |
| XJR · iShares Trust | · | 3458 SH | 2026年8月31日 | 每日 |
| SVAL · iShares Trust | · | 5101 SH | 2026年9月3日 | 每日 |
| ISCB · iShares Trust | · | 1008 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 3047 SH | 2026年9月11日 | 每日 |
ICUI 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$192.50
+20.8%
5 38.5%
强烈买入
7 53.8%
买入
1 7.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-10-01平均目标 $193.38 +21.3%
← 低于所有目标
当前价格 $159.38
最低$178.00
平均值$193.38
最高$210.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
| STAA | $1.17B | -14.6 | -23.7% | -33.6% | -23.6% | 76.2% |
| BVS | · | 22.5 | -0.91% | 4.0% | 13.7% | 68.3% |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报